In this line the GP-41 envelope protein of the human immuno-deficiency virus (HIV) [21] and a secreted peptide from Herpes simplex virus-2 (HSV) [22] were shown to specifically activate the FPR1 receptor, and hence to modulate innate immunity during viral infection. This evidence concerns the gene ERVW-1 and viral infectious disease.